Navigation Links
Insurance Data Show High Costs of Persistent Asthma

Patients with persistent asthma incur high medical costs as well as indirect costs for employers, reports a study in the August Journal of Occupational and Environmental// Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

Led by Dr. Gene Colice of Washington Hospital Center, Washington, D.C., the researchers used a large insurance database to analyze costs associated with persistent asthma. Patients were classified as having persistent asthma if they suffered from asthma attacks at least twice weekly (among other criteria). The analysis included nearly 3,000 patients with persistent asthma, including employees and dependents covered by insurance plans at 17 U.S. companies.

Direct medical costs for patients with persistent asthma averaged about $6,500 per year, compared to just over $2,000 for patients without asthma. Thus, direct costs for a patient with persistent asthma were $4,500 higher than for nonasthma patients.

Data on 443 employees with persistent asthma also showed high indirect costs—costs from disability and missed work days. On average, annual indirect costs were $924 higher for workers with persistent asthma. The differences in direct and indirect costs remained significant after statistical adjustment for other factors.

Further analysis compared costs for workers with mild, moderate, and severe persistent asthma. Costs were highest for patients with severe persistent asthma who have continual asthma symptoms causing significant limitations in physical activity.

Surprisingly, there was no significant difference in costs between patients with moderate persistent asthma, who have asthma attacks at least twice weekly; and those with moderate persistent asthma, who have daily attacks. This probably reflected the low rate of treatment with inhaled steroids—the most effective medications for controlling asthma—by patients in the mild group. Le ss than 10 percent of patients with mild persistent asthma used inhaled steroids on a daily basis, compared to 80 percent or more of those with moderate to severe persistent asthma.

Asthma is a common chronic disease in adults as well as children. Asthma-related medical costs have been estimated at $12.7 billion per year in the United States. However, few studies of asthma costs have used data from insurance claims databases, which provide a more realistic reflection of costs.

"Persistent asthma is an expensive chronic condition for both third-party payers and employers," Dr. Colice and colleagues conclude. Direct medical costs are substantially higher than for employees and dependents without asthma. Since factors such as reduced productivity weren't included, the study probably underestimates the true impact on indirect costs. The researchers highlight the potential for health and economic benefits by increasing use of regular inhaled steroid therapy among patients with mild persistent asthma.

(Source: Newswise
'"/>




Related medicine news :

1. Changing Trends Regarding Insurance Cover For Weight Reduction Surgery
2. Increase In Health Insurance Premium Likely In Australia
3. Health Insurance Scheme Generates Conflicting Opinions
4. Cancer Cover Insurance “The Big V” Is Launched In U.
5. Hospitals Health Insurance Scam Uncovered
6. Arkansas Governor Explains New Health Plan Insurance On Radio Show
7. Hartford To Offer Life Insurance To Cancer Survivors
8. BPL Families To Receive Health Insurance: Andhra CM
9. Health Insurance Fueling Medical Crisis in US
10. Health Insurance Numbers Declining In American Families
11. Medicare Drug Plans Might Rest With Three Major Insurance Companies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: